Organoid Industrialization
This Genetic Engineering & Biotechnology News article explores the industrialization of organoids for advanced drug discovery. Inside, Victoria Marsh Durban, PhD, speaks to Molecular Devices’ custom organoid expansion service, using proprietary bioreactor and bioprocessing technology to produce millions of organoids. This breakthrough addresses the demands of biotech and pharmaceutical companies seeking reliable, complex cell models at scale.